Congressionally Directed Medical Research Programs
127
57
63
40
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.6%
2 terminated/withdrawn out of 127 trials
95.2%
+8.7% vs industry average
3%
4 trials in Phase 3/4
35%
14 of 40 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (127)
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
Role: collaborator
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
Role: collaborator
Cognitive Rehabilitation for Treatment of Anger in Veterans With TBI and PTSD
Role: collaborator
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Role: collaborator
LMN-201 for Prevention of C. Difficile Infection Recurrence
Role: collaborator
This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria
Role: collaborator
Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Role: collaborator
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
Role: collaborator
At-Home Genital Nerve Stimulation for SCI Bowel
Role: collaborator
Duraplasty for Acute Traumatic Spinal Cord Injury
Role: collaborator
Peripheral Interfaces in Amputees for Sensorimotor Integration
Role: collaborator
Ultrasound Imaging of Kidney Stones and Lithotripsy
Role: collaborator
Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder
Role: collaborator
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Role: collaborator
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Role: collaborator
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
Role: collaborator
Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
Role: collaborator
AIH-induced Walking Recovery After Subacute SCI
Role: collaborator
Promoting Recovery Outcomes Through Precise Early Locomotor Interventions in Persons With Spinal Cord Injury
Role: collaborator
Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI
Role: collaborator